BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15324824)

  • 1. Levetiracetam as add-on therapy in generalised epilepsies.
    Kumar SP; Smith PE
    Seizure; 2004 Oct; 13(7):475-7. PubMed ID: 15324824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P; McCarthy M; Doherty CP; Delanty N
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam monotherapy for primary generalised epilepsy.
    Cohen J
    Seizure; 2003 Apr; 12(3):150-3. PubMed ID: 12651079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam in refractory epilepsy: a prospective observational study.
    Mohanraj R; Parker PG; Stephen LJ; Brodie MJ
    Seizure; 2005 Jan; 14(1):23-7. PubMed ID: 15642496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study.
    Labate A; Colosimo E; Gambardella A; Leggio U; Ambrosio R; Quattrone A
    Seizure; 2006 Apr; 15(3):214-8. PubMed ID: 16420982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam in the treatment of idiopathic generalized epilepsies.
    Grünewald R
    Epilepsia; 2005; 46 Suppl 9():154-60. PubMed ID: 16302890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy.
    Rocamora R; Wagner K; Schulze-Bonhage A
    Seizure; 2006 Sep; 15(6):428-33. PubMed ID: 16837220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of levetiracetam in treating epilepsy associated with other medical conditions.
    Di Bonaventura C; Mari F; Fattouch J; Egeo G; Vaudano AE; Manfredi M; Prencipe M; Giallonardo AT
    Acta Neurol Scand; 2006 Feb; 113(2):82-6. PubMed ID: 16411967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram--a pilot study.
    Goldberg-Stern H; Feldman L; Eidlitz-Markus T; Kramer U; Perez S; Pollak L; Phatal-Valevski A
    Eur J Paediatr Neurol; 2013 May; 17(3):248-53. PubMed ID: 23159714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of compassionate use of Levetiracetam in patients with generalised epilepsy.
    Weber S; Beran RG
    J Clin Neurosci; 2004 Sep; 11(7):728-31. PubMed ID: 15337134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes.
    Di Bonaventura C; Fattouch J; Mari F; Egeo G; Vaudano AE; Prencipe M; Manfredi M; Giallonardo AT
    Epileptic Disord; 2005 Sep; 7(3):231-5. PubMed ID: 16162433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience with levetiracetam for adults with epilepsy].
    Barcs G; Szucs A
    Ideggyogy Sz; 2007 Jan; 60(1-2):31-4. PubMed ID: 17432091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial.
    Lagae L; Buyse G; Ceulemans B
    Seizure; 2005 Jan; 14(1):66-71. PubMed ID: 15642504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.
    Noachtar S; Andermann E; Meyvisch P; Andermann F; Gough WB; Schiemann-Delgado J;
    Neurology; 2008 Feb; 70(8):607-16. PubMed ID: 18285535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of levetiracetam for partial seizures.
    Abou-Khalil B; Schaich L
    Seizure; 2005 Dec; 14(8):577-85. PubMed ID: 16280250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of levetiracetam in refractory childhood epilepsy syndromes.
    Lagae L; Buyse G; Deconinck A; Ceulemans B
    Eur J Paediatr Neurol; 2003; 7(3):123-8. PubMed ID: 12788038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.